<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The majority of the <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> arising in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> manifest clinically at an advanced stage and have a poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>As a result of this poor prognosis, much attention has been directed toward the exploration of markers for <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of the present study was to determine the expression of beta-catenin by immunohistochemical analysis in 70 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> developed in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> and to examine its relationship to various prognostic factors currently in use </plain></SENT>
<SENT sid="3" pm="."><plain>Abnormal beta-catenin expression, consisting of the loss of membranous staining and the appearance of the nuclear staining, was found in 43 cases (61%) </plain></SENT>
<SENT sid="4" pm="."><plain>Of patients with the 43 tumors showing abnormal beta-catenin expression, 25 (58%) survived more than 1 year </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, only 7 (26%) of 27 patients with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> showing <z:mpath ids='MPATH_458'>normal</z:mpath> beta-catenin expression survived longer than 1 year </plain></SENT>
<SENT sid="6" pm="."><plain>Most of the superficial (Tis-T1) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (83% [10/12]) exhibited abnormal beta-catenin expression compared with only 53% (31/58) in the T2-T3 group </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest a possible correlation among beta-catenin expression, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage, and length of survival as prognostic factors in patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
</text></document>